HER2-positive breast cancer is a type of breast cancer in which breast cancer cells test positive for a protein receptor called human epidermal.
First-line trastuzumab (Herceptin') plus docetaxel versus docetaxel alone in women with HER2-positive metastatic breast cancer (MBC): Results from a.
The introduction of anti-HER2 therapies to the treatment of patients with HER2- positive breast cancer has led to dramatic improvements in.
HER2-positive breast cancer is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2), which promotes the.
HER2 is a protein that can promote the growth of breast cancer cells. Breast cancer cells with high levels of HER2 are called HER2-positive.